Chih Lung Shen
Director/Board Member at MEDEON BIODESIGN, INC.
Profile
Chih Lung Shen is the founder of Allgenesis Biotherapeutics, Inc. He currently holds positions as an Independent Director at Medeon Biodesign, Inc., Director at EirGenix, Inc., Director at Noratech Pharmaceuticals, Inc., and Managing Member at Cheng Xin Venture Capital Group.
Previously, he served as an Independent Director at Lotus Pharmaceutical Co., Ltd., Director at Mycenax Biotech, Inc., Director at Kiotek Corp., Non-Executive Director at ASLAN Pharmaceuticals Pte Ltd., Director at TWi Pharmaceuticals, Inc., Director at ARDIC Instruments Co., Non-Executive Director at Aslan Pharmaceuticals Ltd., and Member-Supervisory Board at TWi Pharmaceuticals, Inc. and TWi Biotechnology, Inc. He holds a doctorate from the University of Wisconsin and an undergraduate degree from Tsinghua University.
Chih Lung Shen active positions
| Companies | Position | Start |
|---|---|---|
| MEDEON BIODESIGN, INC. | Director/Board Member | 2015-04-19 |
| EIRGENIX INC. | Director/Board Member | 2021-12-05 |
Cheng Xin Venture Capital Group
 Cheng Xin Venture Capital Group Investment ManagersFinance Cheng Xin Venture Capital Group (CXVCG) is a venture capital investment firm located in Taipei, Taiwan. Established in 1990, the firm manages a number of investment funds focusing on high technology and biotechnology firms. | Investment Committee Member | - |
| Noratech Pharmaceuticals, Inc. | Director/Board Member | - |
Former positions of Chih Lung Shen
| Companies | Position | End |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Director/Board Member | 2018-10-29 |
| LOTUS PHARMACEUTICAL CO., LTD. | Director/Board Member | 2014-08-31 |
| TWI PHARMACEUTICALS INC | Director/Board Member | 2014-05-31 |
| TWI PHARMACEUTICALS INC | Director/Board Member | - |
Allgenesis Biotherapeutics, Inc.
 Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Founder | - |
Training of Chih Lung Shen
| University of Wisconsin | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| LOTUS PHARMACEUTICAL CO., LTD. | Health Technology |
| MYCENAX BIOTECH INC. | Health Technology |
| TWI BIOTECHNOLOGY, INC. | Health Technology |
| MEDEON BIODESIGN, INC. | Electronic Technology |
| EIRGENIX INC. | Health Technology |
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 7 |
|---|---|
Cheng Xin Venture Capital Group
Cheng Xin Venture Capital Group Investment ManagersFinance Cheng Xin Venture Capital Group (CXVCG) is a venture capital investment firm located in Taipei, Taiwan. Established in 1990, the firm manages a number of investment funds focusing on high technology and biotechnology firms. | Finance |
Kiotek Corp.
 Kiotek Corp. BiotechnologyHealth Technology Kiotek Corp. researches, develops and manufactures chitosan based products. It offers biotechnological products such as chttins and chitosans that assist in weight loss. The company was founded in 1997 and is headquartered in Hsinchu, Taiwan. | Health Technology |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
| ARDIC Instruments Co. | |
Allgenesis Biotherapeutics, Inc.
Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Health Technology |
| Noratech Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Chih Lung Shen
